Premium
Naltrexone Biotransformation and Incidence of Subjective Side Effects: A Preliminary Study
Author(s) -
King Andrea C.,
Volpicelli Joseph R.,
Gunduz Mithat,
O'Brien Charles P.,
Kreek Mary Jeanne
Publication year - 1997
Publication title -
alcoholism: clinical and experimental research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.267
H-Index - 153
eISSN - 1530-0277
pISSN - 0145-6008
DOI - 10.1111/j.1530-0277.1997.tb03856.x
Subject(s) - naltrexone , biotransformation , side effect (computer science) , incidence (geometry) , medicine , chemistry , computer science , opioid , mathematics , biochemistry , enzyme , receptor , programming language , geometry
When administered orally, naltrexone undergoes extensive biotransformation and is metabolized to 6β‐naltrexol and other minor metabolites. Naltrexone has been recently approved by the Food and Drug Administration for the treatment of alcohol dependence. An important clinical issue with naltrexone treatment is predicting patient compliance, which may be influenced by adverse side effects experienced during the medication. We investigated whether subjective side effects were related to urinary concentrations of naltrexone and its metabolite 6β‐naltrexol 3 hr after administration of 50 mg Po naltrexone in 24 male moderate‐to‐heavy social drinkers. The results showed significantly higher levels of urinary 6β‐naltrexol (p < 0.05) in those subjects who experienced one or more side effect (i.e., headache, nausea, anxiety, or erection). Urinary naltrexone levels did not difter between the groups. Results also showed an approximate 10:1 ratio of 6β‐naltrexol to naltrexone levels and a significant positive correlation between the parent compound and metabolite, suggesting parallel renal clearance. The results of this study suggest a possible mechanism for the side effects obsetved after acute administration of naltrexone.